WARRINGTON, Pa., April 27, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010. The Company will host a conference call on Wednesday, April 28, 2010, at 10:00 AM EDT. The call-in number is 866-332-5218.
